Kristin Andrews on Animal Minds

05/19/20 • 67 min

Are non-human animals conscious? Do non-human animal minds have concepts, intelligence, memory, intentionality, ethics, and social behavior? Kristin Andrews, professor of philosophy, author, and pioneering researcher in moral cognition, discusses non-human animal consciousness and the ethical problems of using non-human animals, like rats, as research subjects. To celebrate the newly released Second Edition of Kristin’s seminal textbook, The Animal Mind, we dive deep into philosophical inquiry on animals and consciousness—how and what animals think, what skills they possess, what moral and social structures they create and live by, and throughout our conversation she tackles the minefield of ethical questions about animal rights and using animals in scientific and medical research. Kristin also candidly describes how she conquered obstacles most women face navigating and succeeding in the largely male-dominated world of academic philosophy. This episode will broaden your perspective on our animal brothers and sisters, and how closely related we truly are.

https://kristinandrews.org/

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit bestofggpodcast.substack.com

https://kristinandrews.org/

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit bestofggpodcast.substack.com

Previous Episode

Sylver Quevedo: Psychedelic-assisted Therapies

Psychedelic-assisted interventions appear to be all the rage these days. Though there are many psychedelic evangelists I wanted to find a credible medical resource to discuss these treatments. Deep gratitude to my friend Ron Purser who introduced me to my esteemed guest, Sylver Quevedo, MD, a pioneer in integrative family and internal medicine, assistant professor of medicine at Stanford and UCSF, co-Founder of Polaris Insight Center for Ketamine-assisted psychotherapy, and Principle Investigator in the FDA clinical trials on MDMA for Post-traumatic Stress Disorder. Our conversation was enlightening and it was fascinating to hear about Dr. Quevedo’s long history of work in public health, his devotion to providing medical care for indigenous populations in the American Southwest and Africa, and his enduring personal and professional interest in clinical use of psychedelic plant medicines. He beautifully explicates the biologic mechanisms of psilocybin, MDMA, ketamine, ayahuasca, mescaline and how these substances differ in effect and usefulness in psychotherapy. Dr. Quevedo is limited in discussing outcomes of the current phase 3 MDMA trials but he shared results of previous MDMA for PTSD trials, as well as use of psilocybin-assisted psychotherapy for end-of-life anxiety, depression, and ketamine-assisted psychotherapy for suicidal depression and chronic pain. So sit back and enjoy the journey this amazing physician takes us on.

https://www.polarisinsight.com/

https://maps.org Multidisciplinary Association for Psychedelic Studies

https://clinicaltrials.gov/ NIH MDMA Studies

Sylver Quevedo, MD, Internist Polaris Co-Founder and Medical Director has been in continuous practice of medicine for 40 years and practices nephrology, family, internal, and integrative medicine. He serves as Assistant Professor at Stanford and UCSF. He has played pivotal roles in several global health projects, including planning and development of medical and nursing school in Africa. The staff at Polaris Insight Center are dedicated to the ethical and compassionate clinical use of ketamine-assisted, and psychedelic-assisted, psychotherapy. Our founding members are all MAPS (Multi-disciplinary Association for Psychedelic Studies) trained clinicians who have participated in both Phase 2 and Phase 3 clinical trials of MDMA-assisted psychotherapy for PTSD.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit bestofggpodcast.substack.com

Next Episode

Eric Garland: Mindfulness and Addiction Recovery

Eric Garland, PhD, LCSW, is a rare combination of rigorous researcher and compassionate clinician. His unique integration of CBT and mindfulness led him to create Mindfulness-Oriented Recovery Enhancement (MORE), an integrative group intervention for treating chronic pain, stress, and opioid misuse. His attention to detail and methodology has made him a trusted researcher. In 2019 he was appointed to the NIH HEAL Multi-Disciplinary Working Group to help guide the HEAL initiative on pain and addiction. Our dialogue was exciting for both of us. We share a sense that helping patients attend to savoring and insight is key to moving beyond the murky grasp of addiction.

Eric Garland, PhD, LCSW, is Distinguished Endowed Chair in Research, Professor, and Associate Dean for Research in the University of Utah College of Social Work, Director of the Center on Mindfulness and Integrative Health Intervention Development (C-MIIND) and, Associate Director of Integrative Medicine in Supportive Oncology and Survivorship at the Hunstman Cancer Institute. Dr. Garland has had over 150 scientific articles and book chapters published in respected, peer-reviewed outlets, and he currently serves as Associate Editor for the journal Mindfulness.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit bestofggpodcast.substack.com